Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

1 min read

Veristat Supports Antibe Therapeutics for Pain and Inflammation Study

Upon receiving approval from Health Canada, Antibe Therapeutics selected Veristat to immediately begin work on part one of a Phase 2B dose-ranging, efficacy study for their lead drug candidate ATB-346.   The study will run in Canada and is expected to conclude in December 2018.

“Veristat is excited to continue our support of Antibe Therapeutics’ ATB-346 program. We are providing full-service clinical support for Antibe’s current and upcoming Phase II dose-ranging efficacy studies,” said Shaheen Limbada, SVP Global Clinical Operations at Veristat, “We look forward to strengthening our long-term partnership with Antibe with continued support of their clinical development programs.”


Veristat’s full-service clinical development solutions are ideal for emerging and small to mid-size biopharmaceutical companies.    We deliver uncompromised value and impact to our clients as we guide them from early phase trial planning and design, through to trial execution, regulatory submission support through to post-approval.  

Read the full Antibe Therapeutics press release on the Antibe Therapeutics website.

 

 


Explore Key Related Services

Veristat Helps Antibe Therapeutics Complete Their Phase IIB Study During COVID-19

Veristat Helps Antibe Therapeutics Complete Their Phase IIB Study During COVID-19

Veristat helps Antibe Therapeutics complete their Phase IIB study during COVID-19 and will deliver top-line results to Antibe in six weeks.

Read More
Veristat Supports 12% of all FDA NME Approvals in 2018, a Record-Setting Year for FDA Approvals

Veristat Supports 12% of all FDA NME Approvals in 2018, a Record-Setting Year for FDA Approvals

Veristat, a scientifically oriented clinical development and regulatory submission partner, announced today that it supported its biopharmaceutical...

Read More
Veristat Strengthens Clinical Operations Capabilities - Acquires Topstone Research

Veristat Strengthens Clinical Operations Capabilities - Acquires Topstone Research

Veristat, a full service Clinical Research Organization (CRO), announced today that it has completed the acquisition of Topstone Research, a...

Read More